UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 827

Sortiert nach

Grade group system and plasma androgen receptor status in the first line treatment for metastatic castration resistant prostate cancer

Scientific reports, 2022-05, Vol.12 (1), p.7319-7319, Article 7319

2022

Volltextzugriff (PDF)

Androgen receptor gain in circulating free DNA and splicing variant 7 in exosomes predict clinical outcome in CRPC patients treated with abiraterone and enzalutamide

Prostate cancer and prostatic diseases, 2021-06, Vol.24 (2), p.524-531

2021

Volltextzugriff (PDF)

Combination radium-223 therapies in patients with bone metastases from castration-resistant prostate cancer: A review

Critical reviews in oncology/hematology, 2020-02, Vol.146, p.102864-102864, Article 102864

2020

Volltextzugriff (PDF)

Treatment of squamous cell carcinoma of the anal canal: A new strategies with anti-EGFR therapy and immunotherapy

Critical reviews in oncology/hematology, 2018-03, Vol.123, p.52-56

2018

Volltextzugriff (PDF)

Longitudinal assessment of plasma androgen receptor copy number predicts overall survival in subsequent treatment lines in castration-resistant prostate cancer: analysis from a prospective trial

ESMO open, 2023-12, Vol.8 (6), p.102036-102036, Article 102036

2023

Volltextzugriff (PDF)

Serial transverse enteroplasty (STEP) in case of short bowel syndrome: did we achieve our goal? A systematic review

Updates in surgery, 2022-08, Vol.74 (4), p.1209-1223

2022

Volltextzugriff (PDF)

Immune inflammation indicators in anal cancer patients treated with concurrent chemoradiation: training and validation cohort with online calculator (ARC: Anal Cancer Response Classifier) [Corrigendum]

Cancer management and research, 2019-06, Vol.11, p.5123-5124

2019

Volltextzugriff (PDF)

Local spin density in the Cr7Ni antiferromagnetic molecular ring and 53Cr-NMR

Journal of physics. Condensed matter, 2012-10, Vol.24 (40), p.406002-406002

2012

Volltextzugriff (PDF)

Systolic Blood Pressure Estimation from PPG Signal Using ANN

Electronics (Basel), 2022-09, Vol.11 (18), p.2909

2022

Volltextzugriff (PDF)

Magnetic properties and hyperfine interactions in Cr₈, Cr₇Cd, and Cr₇Ni molecular rings from ¹⁹F-NMR

The Journal of chemical physics, 2014-04, Vol.140 (14), p.144306-144306

2014

Volltextzugriff (PDF)

Randomness in time-resolved serial crystallography data: alternatives to the binning and averaging approach

Acta crystallographica. Section A, Foundations and advances, 2022-08, Vol.78 (a2), p.e111-e111

2022

Volltextzugriff (PDF)

Plasma tumour DNA as an early indicator of treatment response in metastatic castration-resistant prostate cancer

British journal of cancer, 2020-09, Vol.123 (6), p.982-987

2020

Volltextzugriff (PDF)

1809P Dynamics of plasma tumour DNA and copy number alterations in advanced metastatic castration-resistant prostate cancer (mCRPC) patients treated with cabazitaxel: A prospective biomarker trial

Annals of oncology, 2023-10, Vol.34, p.S979-S979

2023

Volltextzugriff (PDF)

601P The prognostic role of longitudinal assessment of plasma androgen receptor (AR) copy number (CN) in metastatic castration-resistant prostate cancer (mCRPC): Analysis from a prospective biomarkers trial

Annals of oncology, 2021-09, Vol.32, p.S645-S645

2021

Volltextzugriff (PDF)

OC.13.5 MOTORIZED SPIRAL ENTEROSCOPY: PRELIMINARY RESULTS OF A MULTICENTER, PROSPECTIVE, ITALIAN EXPERIENCE

Digestive and liver disease, 2023-03, Vol.55, p.S123-S123

2023

Volltextzugriff (PDF)

Immune Inflammation Indicators Predict Outcome in Anal Cancer Patients Undergoing Concurrent Chemoradiation

International journal of radiation oncology, biology, physics, 2018-11, Vol.102 (3), p.e5-e6

2018

Volltextzugriff (PDF)

583P Baseline plasma tumour DNA (ptDNA) correlates with PSA kinetics in metastatic castration-resistant prostate cancer (mCRPC) treated with abiraterone or enzalutamide

Annals of oncology, 2021-09, Vol.32, p.S633-S633

2021

Volltextzugriff (PDF)

93PD - Analysis of the androgen receptor status in liquid biopsy to predict the outcome to abiraterone and enzalutamide in CRPC patients

Annals of oncology, 2019-10, Vol.30, p.v26-v26

2019

Volltextzugriff (PDF)

Analysis of the androgen receptor status in liquid biopsy to predict the outcome to abiraterone and enzalutamide in CRPC patients

Annals of oncology, 2019-10, Vol.30, p.v26

2019

Volltextzugriff (PDF)

EP-1487: The prognostic role of haemoglobin in patients undergoing concurrent chemo-radiation for anal cancer

Radiotherapy and oncology, 2018-04, Vol.127, p.S806-S807

2018

Volltextzugriff (PDF)

EP-1461: Immune inflammation indicators in anal cancer patients treated with concurrent chemo-radiation

Radiotherapy and oncology, 2018-04, Vol.127, p.S793-S794

2018

Volltextzugriff (PDF)

739P Impact of previous nephrectomy on clinical outcome of metastatic renal carcinoma treated with immuno-oncology: A real-world study on behalf of Meet-URO group (MeetUro-7b)

Annals of oncology, 2020-09, Vol.31, p.S576-S576

2020

Volltextzugriff (PDF)

800TiP Meet-URO 12: A randomized phase II trial of niraparib versus best supportive care (BSC) as maintenance treatment in patients with locally advanced or metastatic urothelial cancer (UC) whose disease did not progress after completion of first-line platinum-based chemotherapy

Annals of oncology, 2020-09, Vol.31, p.S607-S607

2020

Volltextzugriff (PDF)

Radiotherapy as an Immunological Booster in Patients with Metastatic Melanoma or Renal Cell Carcinoma Treated with High-Dose Interleukin-2: Final Data

Annals of oncology, 2019-12, Vol.30, p.xi44-xi45

2019

Volltextzugriff (PDF)

1 – 25 von 827

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(657)
Mit Volltextzugriff
(655)

Publikationsform

Sprache

4 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(412)
Humans
(277)
Life Sciences & Biomedicine
(272)
Female
(164)
Male
(138)
Middle Aged
(117)
Technology
(109)
Adult
(99)
Aged
(88)
Biological And Medical Sciences
(87)
Engineering
(84)
Medical Sciences
(82)
Engineering, Electrical & Electronic
(80)
Oncology
(60)
Computer Science
(56)
Computer Science, Theory & Methods
(47)
Surgery
(45)
Computer Science, Information Systems
(44)
Physical Sciences
(43)
Self Organizing Systems
(42)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Grade group system and plasma androgen receptor status in the first line treatment for metastatic castration resistant prostate cancer

Androgen receptor gain in circulating free DNA and splicing variant 7 in exosomes predict clinical outcome in CRPC patients treated with abiraterone and enzalutamide

Combination radium-223 therapies in patients with bone metastases from castration-resistant prostate cancer: A review

Treatment of squamous cell carcinoma of the anal canal: A new strategies with anti-EGFR therapy and immunotherapy

Longitudinal assessment of plasma androgen receptor copy number predicts overall survival in subsequent treatment lines in castration-resistant prostate cancer: analysis from a prospective trial

Serial transverse enteroplasty (STEP) in case of short bowel syndrome: did we achieve our goal? A systematic review

Immune inflammation indicators in anal cancer patients treated with concurrent chemoradiation: training and validation cohort with online calculator (ARC: Anal Cancer Response Classifier) [Corrigendum]

Local spin density in the Cr7Ni antiferromagnetic molecular ring and 53Cr-NMR

Systolic Blood Pressure Estimation from PPG Signal Using ANN

Magnetic properties and hyperfine interactions in Cr₈, Cr₇Cd, and Cr₇Ni molecular rings from ¹⁹F-NMR

Randomness in time-resolved serial crystallography data: alternatives to the binning and averaging approach

Plasma tumour DNA as an early indicator of treatment response in metastatic castration-resistant prostate cancer

1809P Dynamics of plasma tumour DNA and copy number alterations in advanced metastatic castration-resistant prostate cancer (mCRPC) patients treated with cabazitaxel: A prospective biomarker trial

601P The prognostic role of longitudinal assessment of plasma androgen receptor (AR) copy number (CN) in metastatic castration-resistant prostate cancer (mCRPC): Analysis from a prospective biomarkers trial

OC.13.5 MOTORIZED SPIRAL ENTEROSCOPY: PRELIMINARY RESULTS OF A MULTICENTER, PROSPECTIVE, ITALIAN EXPERIENCE

Immune Inflammation Indicators Predict Outcome in Anal Cancer Patients Undergoing Concurrent Chemoradiation

583P Baseline plasma tumour DNA (ptDNA) correlates with PSA kinetics in metastatic castration-resistant prostate cancer (mCRPC) treated with abiraterone or enzalutamide

Immune inflammation indicators in anal cancer patients treated with concurrent chemoradiation: training and validation cohort with online calculator (ARC: Anal Cancer Response Classifier)

93PD - Analysis of the androgen receptor status in liquid biopsy to predict the outcome to abiraterone and enzalutamide in CRPC patients

Analysis of the androgen receptor status in liquid biopsy to predict the outcome to abiraterone and enzalutamide in CRPC patients

EP-1487: The prognostic role of haemoglobin in patients undergoing concurrent chemo-radiation for anal cancer

EP-1461: Immune inflammation indicators in anal cancer patients treated with concurrent chemo-radiation

739P Impact of previous nephrectomy on clinical outcome of metastatic renal carcinoma treated with immuno-oncology: A real-world study on behalf of Meet-URO group (MeetUro-7b)

800TiP Meet-URO 12: A randomized phase II trial of niraparib versus best supportive care (BSC) as maintenance treatment in patients with locally advanced or metastatic urothelial cancer (UC) whose disease did not progress after completion of first-line platinum-based chemotherapy

Radiotherapy as an Immunological Booster in Patients with Metastatic Melanoma or Renal Cell Carcinoma Treated with High-Dose Interleukin-2: Final Data

Suchergebnisse filtern